Hemogenyx Pharmaceuticals Plc

(LSE) HEMO

Current Price$674.00

Market Cap$4.34B

Since IPO (2017)-44%

5 Year-38%

1 Year+267%

1 Month-31%

Hemogenyx Pharmaceuticals Plc Financials at a Glance

Market Cap

$4.34B

Revenue (TTM)

$0.00

Net Income (TTM)

$10.18M

EPS (TTM)

$-221.60

P/E Ratio

-3.05

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$674.00

Volume

43,466

Open

$676.00

Price

$674.00

Volume

43,466

Open

$676.00

Previous Close

$674.00

Daily Range

$652.00 - $690.00

52-Week Range

$124.27 - $1800.00

Dividend

$0.00

Beta (Volatility)

0.01 (Low)

Price

$674.00

Volume

43,466

Open

$676.00

Previous Close

$674.00

Daily Range

$652.00 - $690.00

52-Week Range

$124.27 - $1800.00

HEMO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hemogenyx Pharmaceuticals Plc

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Vladislav Sandler, PhD

Website

www.hemogenyx.com

Headquarters

London, EC3V 0HR, GB

HEMO Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-609%

Return on Capital

-3%

Return on Assets

-3%

Earnings Yield

-32.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.34B

Shares Outstanding

6.43M

Volume

43.47K

Avg. Volume

29.22K

Financials (TTM)

Gross Profit

$639.28K

Operating Income

$5.73M

EBITDA

$4.71M

Operating Cash Flow

$4.12M

Capital Expenditure

$13.28K

Free Cash Flow

$4.13M

Cash & ST Invst.

$159.26K

Total Debt

$2.62M

Hemogenyx Pharmaceuticals Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$313.78K

+1.9%

Gross Margin

0.00%

N/A

Market Cap

$4.34B

N/A

Market Cap/Employee

$271.07M

N/A

Employees

N/A

Net Income

$5.00M

-15.8%

EBITDA

$4.57M

-19.0%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$1.98M

-996.9%

Accounts Receivable

$343.09K

+328.3%

Inventory

$0.00

+100.0%

Long Term Debt

$1.79M

-36.5%

Short Term Debt

$827.03K

+84.7%

Return on Assets

-2.52%

N/A

Return on Invested Capital

-2.96%

N/A

Free Cash Flow

$3.79M

-13.3%

Operating Cash Flow

$3.78M

-13.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CREO.LCreo Medical Limited

CREO.LCreo Medical Limited$12.63-2.88%

HVO.LhVIVO plc

HVO.LhVIVO plc$7.30-2.67%

KOO.LKooth plc

KOO.LKooth plc$128.50+0.00%

POLB.LPoolbeg Pharma PLC

POLB.LPoolbeg Pharma PLC$4.30-3.37%

SAR.LSareum Holdings plc

SAR.LSareum Holdings plc$20.25-1.22%

SBTX.LSkinBioTherapeutics Plc

SBTX.LSkinBioTherapeutics Plc$9.75-4.88%

IMM.LImmuPharma plc

IMM.LImmuPharma plc$4.14+2.22%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RBLXRoblox

RBLXRoblox$45.13-0.18%

Questions About HEMO

What is the current price of Hemogenyx Pharmaceuticals Plc?

Hemogenyx Pharmaceuticals Plc is trading at GBX 674.00 per share.

What is the 52-week range for Hemogenyx Pharmaceuticals Plc?

Over the past 52 weeks, Hemogenyx Pharmaceuticals Plc has traded between GBX 124.27 and GBX 1,800.00.

How much debt does Hemogenyx Pharmaceuticals Plc have?

As of the most recent reporting period, Hemogenyx Pharmaceuticals Plc reported total debt of $2.62M.

How much cash does Hemogenyx Pharmaceuticals Plc have on hand?

Hemogenyx Pharmaceuticals Plc reported $159,265 in cash and cash equivalents in its most recent financial results.

What is Hemogenyx Pharmaceuticals Plc’s dividend yield?

Hemogenyx Pharmaceuticals Plc does not currently have a dividend yield.

Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc Financials at a Glance

HEMO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Hemogenyx Pharmaceuticals Plc

HEMO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Hemogenyx Pharmaceuticals Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HEMO

What is the current price of Hemogenyx Pharmaceuticals Plc?

What is the 52-week range for Hemogenyx Pharmaceuticals Plc?

How much debt does Hemogenyx Pharmaceuticals Plc have?

How much cash does Hemogenyx Pharmaceuticals Plc have on hand?

What is Hemogenyx Pharmaceuticals Plc’s dividend yield?

Premium Investing Services